Related Experiment Video
Updated: Jul 13, 2026

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
1Beckman Center for Molecular and Genetic Medicine, Howard Hughes Medical Institute, Stanford University School of Medicine, California 94305.
Abstract:
The immunosuppressive drugs cyclosporin A (CsA) and FK506 both interfere with a Ca(2+)-sensitive T-cell signal transduction pathway, thereby preventing the activation of specific transcription factors (such as NF-AT and NF-IL2A) involved in lymphokine gene expression. CsA and FK506 seem to act by interaction with their cognate intracellular receptors, cyclophilin and FKBP, respectively (see ref. 11 for review). The Ca2+/calmodulin-regulated phosphatase calcineurin is a major target of drug-isomerase complexes in vitro. We have therefore tested the hypothesis that this interaction is responsible for the in vivo effects of CsA/FK506. We report here that overexpression of calcineurin in Jurkat cells renders them more resistant to the effects of CsA and FK506 and augments both NFAT- and NFIL2A-dependent transcription. These results identify calcineurin as a key enzyme in the T-cell signal transduction cascade and provide biological evidence to support the notion that the interaction of drug-isomerase complexes with calcineurin underlies the molecular basis of CsA/FK506-mediated immunosuppression.
Insights
Overexpressing calcineurin in T-cells makes them resistant to immunosuppressive drugs like cyclosporin A (CsA) and FK506. This finding reveals calcineurin
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Cyclosporin A (CsA) and FK506 are immunosuppressive drugs impacting T-cell activation.
- These drugs interfere with calcium-dependent signaling pathways crucial for lymphokine gene expression.
- CsA and FK506 bind intracellular receptors, cyclophilin and FKBP, respectively.
Purpose of the Study:
- To investigate the role of calcineurin in the mechanism of action of CsA and FK506.
- To test the hypothesis that calcineurin interaction with drug-receptor complexes mediates immunosuppression.
Main Methods:
- Overexpression of calcineurin in Jurkat T-cells.
- Assessing cellular resistance to CsA and FK506.
- Measuring NFAT- and NF-IL2A-dependent transcription.
Main Results:
- Calcineurin overexpression conferred resistance to CsA and FK506 in Jurkat cells.
- Enhanced calcineurin activity augmented NFAT- and NF-IL2A-dependent transcription.
- Demonstrated a direct link between calcineurin activity and drug response.
Conclusions:
- Calcineurin is a critical enzyme in T-cell signal transduction.
- Drug-isomerase complex interaction with calcineurin is the molecular basis for CsA/FK506 immunosuppression.
- Provides biological evidence supporting calcineurin's role in immunosuppressive drug efficacy.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Regulation of Angiogenesis and Blood Supply
Amplifying Signals via Enzymatic Cascade
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

